Adenocarcinoma of the Rectum Completed Phase 3 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00025337Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedTreatment